OLANZAPINE CH olanzapine 2.5 mg tablets bottle

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

olanzapine, Quantity: 2.5 mg

Disponible depuis:

Amneal Pharma Australia Pty Ltd

DCI (Dénomination commune internationale):

Olanzapine

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients: lactose monohydrate; magnesium stearate; crospovidone; hyprolose

Mode d'administration:

Oral

Unités en paquet:

30

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Olanzapine is indicated for the treatment of schizophrenia and related psychoses. ,Olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,Olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Descriptif du produit:

Visual Identification: Yellow coloured, circular, biconvex uncoated tablets, debossed with "C" on one side and "45" on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Statut de autorisation:

Licence status A

Date de l'autorisation:

2011-11-15